IL-1β is also identified as a significant factor in oral-pathogen mediated gut inflammation, as treatment with IL-1 receptor antagonist largely attenuated colitis in germ-free mice colonized with a periodontitis-associated oral microbiota. This evidence concerns the gene IL1B and periodontitis.